Loading...

5N Plus Inc.

FPLSFPNK
Basic Materials
Chemicals - Specialty
$11.44
$0.35(3.16%)

5N Plus Inc. (FPLSF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for 5N Plus Inc. (FPLSF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
19.35%
19.35%
Operating Income Growth
17.74%
17.74%
Net Income Growth
-4.72%
4.72%
Operating Cash Flow Growth
-139.92%
139.92%
Operating Margin
12.74%
12.74%
Gross Margin
27.51%
27.51%
Net Profit Margin
6.94%
6.94%
ROE
15.27%
15.27%
ROIC
12.08%
12.08%

5N Plus Inc. (FPLSF) Income Statement & Financial Overview

View the income breakdown for 5N Plus Inc. FPLSF across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$88.89M$70.85M$78.83M$74.58M
Cost of Revenue$61.89M$51.10M$57.90M$54.38M
Gross Profit$27.00M$19.75M$20.92M$20.20M
Gross Profit Ratio$0.30$0.28$0.27$0.27
R&D Expenses$1.11M$0.00$0.00$1.21M
SG&A Expenses$9.95M$9.86M$8.13M$8.70M
Operating Expenses$11.88M$13.60M$11.43M$11.05M
Total Costs & Expenses$73.78M$64.70M$69.33M$65.43M
Interest Income$0.00$0.00$0.00$272000.00
Interest Expense$2.72M$2.45M$2.64M$2.15M
Depreciation & Amortization$4.45M$4.43M$4.49M$4.11M
EBITDA$20.28M$10.30M$14.43M$13.53M
EBITDA Ratio$0.23$0.15$0.18$0.18
Operating Income$15.11M$6.15M$9.49M$9.15M
Operating Income Ratio$0.17$0.09$0.12$0.12
Other Income/Expenses (Net)-$2.003M-$2.73M-$2.19M-$1.88M
Income Before Tax$13.11M$3.42M$7.30M$7.27M
Income Before Tax Ratio$0.15$0.05$0.09$0.10
Income Tax Expense$3.54M$2.42M$931000.00$2.48M
Net Income$9.57M$1.006M$6.37M$4.79M
Net Income Ratio$0.11$0.01$0.08$0.06
EPS$0.11$0.01$0.07$0.05
Diluted EPS$0.11$0.01$0.07$0.05
Weighted Avg Shares Outstanding$89.04M$88.95M$88.95M$95.78M
Weighted Avg Shares Outstanding (Diluted)$89.84M$89.75M$89.75M$89.60M

Over the past four quarters, 5N Plus Inc. demonstrated steady revenue growth, increasing from $74.58M in Q2 2024 to $88.89M in Q1 2025. Operating income reached $15.11M in Q1 2025, maintaining a consistent 17% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $20.28M, reflecting operational efficiency. Net income rose to $9.57M, with EPS at $0.11. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;